A short nap, some fresh air, a painkiller—for most people, headaches are a bothersome but manageable issue. Not so for those ...

Preventive treatment with the calcitonin gene-related peptide (CGRP) receptor monoclonal antibody erenumab for 6 weeks was not associated with significant reductions in weekly headache attacks, pain ...

Compared with placebo, eptinezumab failed to significantly reduce the number of episodic cluster headache (ECH) attacks but showed higher responder rates and improved quality-of-life measures. "Among ...

Please provide your email address to receive an email when new articles are posted on . Approximately one in 1,000 people have cluster headaches. Cluster headaches are nicknamed “suicide headaches” ...

The FDA approved dihydroergotamine (DHE) mesylate injection (Brekiya) to treat acute migraine (with or without aura) and cluster headaches in adults, Amneal Pharmaceuticals announced Thursday. The ...

Prednisone is a corticosteroid that’s commonly used across a wide range of medical specialties for its anti-inflammatory properties. In neurology, it has emerged as a therapeutic option for the acute ...

In a paper published in the May issue of JAMA, M. S. Robbins, of Weill Cornell Medical College, reviews the diagnosis, prevention, and treatment of primary headaches. In a previous post, I discussed ...